• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchNeumora Therapeutics
    Picture of Neumora Therapeutics logo

    NMRA — Neumora Therapeutics Share News

    $0.380.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapSucker Stock
    • Market Cap
      $71.29m
    • Enterprise Value
      $7.37m
    • Revenue
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • NMRA Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    NMRA Dividends
    • Brief: Amgen Inc. Reports 23.2% Stake In Neumora Therapeutics As Of September 19- SEC Filing

      27/09/2023 12:51
    • U.S. STOCKS ON THE MOVE-Knowles, RE/MAX Holdings, BioCryst Pharma

      18/09/2023 19:30
    • U.S. STOCKS ON THE MOVE-Ralph Lauren, Lyft, natgas firms

      18/09/2023 17:28
    • Neumora Therapeutics extends drop after listless debut

      18/09/2023 14:46
    • U.S. STOCKS ON THE MOVE-Paramount Global, Canopy Growth, Moderna

      15/09/2023 18:50
    • SoftBank-backed Neumora slumps in dull Nasdaq debut after $250 mln IPO

      15/09/2023 17:43
    • SoftBank-backed Neumora bags $2.51 billion valuation in lackluster debut (updated)

      15/09/2023 17:36
    • SoftBank-backed Neumora's shares fall in Nasdaq debut

      15/09/2023 17:31
    • U.S. STOCKS ON THE MOVE-PTC Therapeutics, Gold miners, Copper miners

      15/09/2023 16:58
    • U.S. STOCKS ON THE MOVE-KeyCorp, General Motors, Applied Materials

      15/09/2023 14:24
    • U.S. STOCKS ON THE MOVE-Arm Holdings, Walt Disney, Morphosys

      15/09/2023 12:45
    • SoftBank-backed Neumora poised for Nasdaq debut after $250-mln IPO

      15/09/2023 10:06
    • Brief: Neumora Therapeutics Announces Pricing Of Initial Public Offering

      15/09/2023 01:50
    Previous1234Next

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.